O'Brien S - Search Results

1

Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial.

Shanafelt TD, Wang XV, Hanson CA, Paietta EM, O'Brien S, Barrientos J, Jelinek DF, Braggio E, Leis JF, Zhang CC, Coutre SE, Barr PM, Cashen AF, Mato AR, Singh AK, Mullane MP, Little RF, Erba H, Stone RM, Litzow M, Tallman M, Kay NE. Shanafelt TD, et al. Blood. 2022 Jul 14;140(2):112-120. doi: 10.1182/blood.2021014960. Blood. 2022. PMID: 35427411 Free PMC article. Clinical Trial.

2

Interferon maintenance therapy for patients with chronic lymphocytic leukemia in remission after fludarabine therapy.

O'Brien S, Kantarjian H, Beran M, Robertson LE, Koller C, Lerner S, Keating MJ. O'Brien S, et al. Blood. 1995 Aug 15;86(4):1298-300. Blood. 1995. PMID: 7632936 Clinical Trial.

3

Advances in the biology and treatment of B-cell chronic lymphocytic leukemia.

O'Brien S, del Giglio A, Keating M. O'Brien S, et al. Blood. 1995 Jan 15;85(2):307-18. Blood. 1995. PMID: 7811987 Free article. Review.

4

Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.

O'Brien S, Kantarjian H, Beran M, Smith T, Koller C, Estey E, Robertson LE, Lerner S, Keating M. O'Brien S, et al. Blood. 1993 Sep 15;82(6):1695-700. Blood. 1993. PMID: 8400226 Free article. Clinical Trial.

5

Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent.

Keating MJ, O'Brien S, Kantarjian H, Plunkett W, Estey E, Koller C, Beran M, Freireich EJ. Keating MJ, et al. Blood. 1993 Jun 1;81(11):2878-84. Blood. 1993. PMID: 8499626 Free article. Clinical Trial.

6

National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment.

Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR. Cheson BD, et al. Blood. 1996 Jun 15;87(12):4990-7. Blood. 1996. PMID: 8652811 Free article. No abstract available.

7

Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy.

Keating MJ, O'Brien S, Lerner S, Koller C, Beran M, Robertson LE, Freireich EJ, Estey E, Kantarjian H. Keating MJ, et al. Blood. 1998 Aug 15;92(4):1165-71. Blood. 1998. PMID: 9694704 Free article. Clinical Trial.

8

NCCN Practice Guidelines for Chronic Myelogenous Leukemia.

Berman E, Clift RA, Copelan EA, Emanuel PD, Erba HP, Glenn MJ, Greenberg PL, Jones RJ, O'Brien S, Saba HI, Schilder R, Snyder DS, Soiffer RJ, Tallman MS, Wetzler M, Ravandi-Kashani F, Kantarjian H, Talpaz M; National Comprehensive Cancer Network. Berman E, et al. Oncology (Williston Park). 2000 Nov;14(11A):229-40. Oncology (Williston Park). 2000. PMID: 11195415 No abstract available.

9

Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts.

Estey EH, Thall PF, Cortes JE, Giles FJ, O'Brien S, Pierce SA, Wang X, Kantarjian HM, Beran M. Estey EH, et al. Blood. 2001 Dec 15;98(13):3575-83. doi: 10.1182/blood.v98.13.3575. Blood. 2001. PMID: 11739159 Free article. Clinical Trial.

10

Chronic lymphocytic leukemia: current and emerging treatment approaches.

Kay NE, Rai KR, O'Brien S. Kay NE, et al. Clin Adv Hematol Oncol. 2006 Nov;4(11 Suppl 22):1-10; quiz 11-2. Clin Adv Hematol Oncol. 2006. PMID: 17143256 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,040 results

Search Page